Cargando…
Right data for right patient—a precisionFDA NCI–CPTAC Multi-omics Mislabeling Challenge
To address a critical roadblock that can occur in translational and clinical research, the National Cancer Institute and the Food and Drug Administration, in coordination with the DREAM Challenges, are launching the first computational challenge using multi-omics datasets to detect and correct speci...
Autores principales: | Boja, Emily, Težak, Živana, Zhang, Bing, Wang, Pei, Johanson, Elaine, Hinton, Denise, Rodriguez, Henry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892367/ https://www.ncbi.nlm.nih.gov/pubmed/30194412 http://dx.doi.org/10.1038/s41591-018-0180-x |
Ejemplares similares
-
A community effort to identify and correct mislabeled samples in proteogenomic studies
por: Yoo, Seungyeul, et al.
Publicado: (2021) -
PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regions
por: Olson, Nathan D., et al.
Publicado: (2022) -
FDA perspectives on potential microarray-based clinical diagnostics
por: Težak, Živana, et al.
Publicado: (2006) -
Reproducibility
of Differential Proteomic Technologies
in CPTAC Fractionated Xenografts
por: Tabb, David L., et al.
Publicado: (2015) -
An Efficient Algorithm for the Detection of Outliers in Mislabeled Omics Data
por: Sun, Hongwei, et al.
Publicado: (2021)